Back to Awarded Treatment Trials
Awarded Trial: 02I-008
Grant ID
02I-008
Illness
Bipolar Depression
Primary Drug/Intervention
Danshen
Primary Dosage
200 mg t.i.d.
Secondary Drug Intervention
N/A
Secondary Dosage
N/A
Other Drug/Intervention
N/A
Other Dosage
N/A
Status
Completed
Investigator
Wang
Sample Size
140
Duration of Study Period for Each Subject
12 weeks
Outcome Measurements
HDRS, CGI-S, TESS
Results
One hundred and forty-two (142) elderly individuals with bipolar depression were randomized to adjunct Danshen or placebo for 12 weeks. There was no difference in clinical efficacy. Those on Danshen had fewer non-perseverative errors on the Wisconsin Card Sort (p<0.05), but this was not corrected for multiple measures.
Publication
N/A
Link
N/A
PI Name
Liwei Wang
Degree
MD
Center
N/A
Institution
Huashan Hospital, Fudan University Medical School
Address
12 Central Urumoi Road, Dept. of Psychiatry
City or Town
Shanghai
State or Province
N/A
Zip or Postal Code
200040
Country
China
Email Address
liweixu@online.sh.cn